Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects have to read and sign the approved the Informed Consent form prior to any participation in the study.~* Male or female Subjects, aged upper to 40 years.~* Osteoarthritis of the knee confirmed by radiological examination.~* Visual analogue scale (VAS) \> 40 mm.~* Kellgren and Lawrence grade 1 to 3.~* Clinical diagnosis of pain and functional limitation.~Exclusion Criteria:~* History of significant trauma or surgery in the affected joint.~* Pregnant women, lactating or not using appropriate contraceptive method.~* History or presence of active rheumatic disease that may be responsible for secondary osteoarthritis.~* Severe inflammation of the joint confirmed by physical examination (excluding also erythrocyte sedimentation \<40mm/h and rheumatoid factor \<1:40).~* Body mass index \> 30.~* Hematologic abnormalities, liver, renal or metabolic functions which undermine the serious participation of the patient (at investigator's criteria).~* Systemic administration and/or intra-articular corticosteroids in the last 3 months.~* Have made use of glucosamine and/or chondroitin.~* Lequesne index of \> 12.~* Arthroplasty in the affected joint.~* Use of narcotic analgesics.~* Any condition that, in the opinion of the investigator, renders the patient unable to participate in the study.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cosamin DS® (Type: ACTIVE_COMPARATOR): glucosamine hydrochloride 500 mg and chondroitin sulfate 400 mg (Cosamin DS®, Nutramax Laboratories).~The medication was supplied as capsules, with the daily dose of 3 capsules.
- Glucosamine/ chondroitin sulphate (Type: EXPERIMENTAL): Glucosamine hydrochloride 500 mg and chondroitin sulphate 400 mg association (Eurofarma) T.I.D. before each meal The medication was supplied as capsules, with the daily dose of 3 capsules.

Based on this trial design, predict the completion outcome and termination type (if applicable).